http://orcid.org/0000-0002-6981-1771
References
- The Global Asthma Report 2014. Auckland, New Zealand: Global Asthma Network, 2014.
- Centers of Disease Control and Prevention. Asthma Surveillance Data. Atlanta, GA: Centers of Disease Control and Prevention; 2016 [cited 2016 14 November]. Available from: http://www.cdc.gov/asthma/asthmadata.htm
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2016. [cited 2016 11 November]. Available from: www.ginasthma.org
- Price D, Martin RJ, Barnes N, Dorinsky P, Israel E, Roche N, Chisholm A, et al. Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study. J Allergy Clin Immunol 2010;126:511–518. e1–e10.
- Hamelmann E, Bernstein JA, Vandewalker M, Moroni-Zentgraf P, Verri D, Unseld A, Engel M, et al. A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma. Eur Respir J 2017;49:1601100.
- Fitzpatrick AM, Jackson DJ, Mauger DT, Boehmer SJ, Phipatanakul W, Sheehan WJ, et al. Individualized therapy for persistent asthma in young children. J Allergy Clin Immunol 2016;138:1608–1618
- Adachi M, Goldfrad C, Jacques L, Nishimura Y. Efficacy and safety comparison: fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial. Respir Med 2016;120:78–86.
- Demarche S, Schleich F, Henket M, Paulus V, Louis R, Van, Hees T. Step-down of inhaled corticosteroids in non-eosinophilic asthma: a prospective trial in real life. Clin Exp Allergy 2018;48:525–535.
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2014 [cited 2014 12 March]. Available from: https://ginasthma.org/
- Campbell JD, Allen-Ramey F, Sajjan SG, Maiese EM, Sullivan SD. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes. Am J Manag Care 2011;17:703–710.
- Price D, Haughney J, Sims E, Ali M, von Ziegenweidt J, Hillyer EV, et al. Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD. J Asthma Allergy 2011;4:37–47.
- Dilokthornsakul P, Lee TA, Dhippayom T, Jeanpeerapong N, Chaiyakunapruk N. Comparison of health care utilization and costs for patients with asthma by severity and health insurance in Thailand. Value Health Reg Issues 2016;9:105–111.
- Dilokthornsakul P, Chaiyakunapruk N, Schumock GT, Lee TA. Calendar time-specific propensity score analysis for observational data: a case study estimating the effectiveness of inhaled long-acting beta-agonist on asthma exacerbations. Pharmacoepidemiol Drug Saf 2014;23:152–164.
- Usmani OS, Kemppinen A, Gardener E, Thomas V, Konduru PR, Callan C, et al. A randomized pragmatic trial of changing to and stepping down fluticasone/formoterol in asthma. J Allergy Clin Immunol Pract 2017;5:1378–1387.
- Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med 2006;100:1139–1151.
- Pola-Bibian B, Dominguez-Ortega J, Vila-Nadal G, Entrala A, Gonzalez-Cavero L, Barranco P, et al. Asthma exacerbations in a tertiary hospital: clinical features, triggers, and risk factors for hospitalization. J Investig Allergol Clin Immunol 2017; 27:238–245.
- Kim CH, Dilokthornsakul P, Campbell JD, van Boven JFM. Asthma cost-effectiveness analyses: Are we using the recommended outcomes in estimating value? J Allergy Clin Immunol Pract 2018;6:619–632.
- Murray CS, Thomas M, Richardson K, Price DB, Turner SW. Comparative effectiveness of step-up therapies in children with asthma prescribed inhaled corticosteroids: A historical cohort study. J Allergy Clin Immunol Pract 2017;5:1082–1090.